Medicare Enrolled
Dr. Randall Berliner, MD
Optician · Bronx, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Berliner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berliner?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Berliner
Dr. Randall Berliner is an optician specialist in Bronx, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Berliner performed 22,438 Medicare services across 430 unique beneficiaries.
Between the years covered by Open Payments, Dr. Berliner received a total of $181,890 from 81 pharmaceutical and/or device companies across 1366 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Berliner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in NY
$181,890 industry payments
Medicare Practice Summary
Medicare Utilization ↗22,438
Medicare services
Top 3% in NY for optician
430
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,122 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
21,001 | $5 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
532 | $114 | $300 |
| 45-minute psychotherapy and evaluation visit A 45-minute session that includes both psychotherapy and an evaluation and management visit. |
227 | $77 | $200 |
| Psychotherapy and evaluation, 30 minutes A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes. |
171 | $61 | $250 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
107 | $44 | $200 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
104 | $147 | $300 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
75 | $59 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
52 | $84 | $200 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
41 | $0 | $10 |
| Annual depression screening | 31 | $21 | $75 |
| Online digital evaluation for established patient, 5-10 minutes This service involves an online digital evaluation and management visit for an established patient. It covers a total time of 5 to 10 minutes over a period of up to 7 days. |
29 | $13 | $250 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $167 | $350 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
24 | $5 | $10 |
| New patient office visit, complex (60-74 min) | 17 | $209 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
94.1% medium
5.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$181,890
Total received (2018-2024)
Avg $25,984/year across 7 years
Top 3% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
1,366
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$165,062 (90.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,731 (8.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,097 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,512
2023
$10,848
2022
$18,215
2021
$28,268
2020
$32,893
2019
$49,308
2018
$36,847
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lundbeck LLC
$2,061
ABBVIE INC.
$1,224
PFIZER INC.
$368
SK Life Science, Inc.
$203
Alexion Pharmaceuticals, Inc.
$175
Neurocrine Biosciences, Inc.
$124
MDD US Operations, LLC
$111
Teva Pharmaceuticals USA, Inc.
$102
Eisai Inc.
$99
Otsuka America Pharmaceutical, Inc.
$92
Vanda Pharmaceuticals Inc.
$92
EMD Serono, Inc.
$81
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$75
Takeda Pharmaceuticals U.S.A., Inc.
$70
Novartis Pharmaceuticals Corporation
$69
Kyowa Kirin, Inc.
$57
Alkermes, Inc.
$53
Neurelis, Inc.
$50
SCILEX PHARMACEUTICALS INC.
$46
Grifols USA, LLC
$37
Lilly USA, LLC
$35
Neuronetics, Inc.
$35
REVANCE THERAPEUTICS, INC.
$33
ARGENX US, INC.
$25
Sumitomo Pharma America, Inc.
$23
IDORSIA PHARMACEUTICALS US INC
$23
Abbott Laboratories
$22
Bausch Health US, LLC
$22
Biogen, Inc.
$21
ANI Pharmaceuticals, Inc.
$19
Genentech USA, Inc.
$19
AstraZeneca Pharmaceuticals LP
$16
Amgen Inc.
$16
Amneal Pharmaceuticals LLC
$14
Top 3 companies account for 66.3% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$37,869
Amgen Inc.
$30,242
Allergan, Inc.
$28,355
Allergan Inc.
$23,216
AbbVie Inc.
$16,507
ABBVIE INC.
$15,721
Lilly USA, LLC
$13,928
Lundbeck LLC
$2,807
Novartis Pharmaceuticals Corporation
$876
MDD US Operations, LLC
$844
PFIZER INC.
$695
Avanir Pharmaceuticals, Inc.
$695
Amneal Pharmaceuticals LLC
$581
EMD Serono, Inc.
$558
Kyowa Kirin, Inc.
$551
Biogen, Inc.
$520
Otsuka America Pharmaceutical, Inc.
$507
Neurocrine Biosciences, Inc.
$462
Alexion Pharmaceuticals, Inc.
$428
Adamas Pharmaceuticals, Inc.
$371
Acorda Therapeutics, Inc
$327
ITI, Inc.
$316
Supernus Pharmaceuticals, Inc.
$314
SK Life Science, Inc.
$308
Takeda Pharmaceuticals U.S.A., Inc.
$297
UCB, Inc.
$288
ACADIA Pharmaceuticals Inc
$254
GENZYME CORPORATION
$239
Eisai Inc.
$198
Shire North American Group Inc
$194
Currax Pharmaceuticals LLC
$193
ARGENX US, INC.
$188
Neurelis, Inc.
$165
Biohaven Pharmaceuticals, Inc.
$164
Mallinckrodt Enterprises LLC
$152
Abbott Laboratories
$121
Vanda Pharmaceuticals Inc.
$119
Neuronetics, Inc.
$118
GE HEALTHCARE
$114
GE HealthCare
$108
Genentech USA, Inc.
$104
Impax Laboratories, Inc.
$102
Janssen Pharmaceuticals, Inc
$93
Alkermes, Inc.
$86
Sunovion Pharmaceuticals Inc.
$85
IDORSIA PHARMACEUTICALS US INC
$82
Axsome Therapeutics, Inc.
$78
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$75
Grifols USA, LLC
$72
Medtronic USA, Inc.
$68
Celgene Corporation
$67
Sumitomo Pharma America, Inc.
$60
Baxter Healthcare
$55
Collegium Pharmaceutical, Inc.
$52
Vertical Pharmaceuticals, LLC
$50
Biohaven Pharmaceutical Holding Company Ltd.
$49
CSL Behring
$47
Scilex Pharmaceuticals Inc.
$46
Life Molecular Imaging Ltd
$46
SCILEX PHARMACEUTICALS INC.
$46
Corium, LLC
$44
Upsher-Smith Laboratories LLC
$43
Alfasigma USA, Inc.
$41
Almatica Pharma LLC
$40
Strongbridge US INC.
$39
US WorldMeds, LLC
$36
Bausch Health US, LLC
$33
REVANCE THERAPEUTICS, INC.
$33
AstraZeneca Pharmaceuticals LP
$31
Assertio Therapeutics, Inc.
$31
Medtronic, Inc.
$30
Brainsway USA INC
$27
Mallinckrodt LLC
$27
IMPEL PHARMACEUTICALS INC.
$24
Horizon Therapeutics plc
$24
GE Healthcare
$21
Promius Pharma LLC
$20
Avion Pharmaceuticals
$20
ANI Pharmaceuticals, Inc.
$19
E.R. Squibb & Sons, L.L.C.
$19
Arbor Pharmaceuticals, Inc.
$16
Top 3 companies account for 53.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APLENZIN · APOKYN · APTIOM · ARISTADA · AUBAGIO · AUSTEDO · AVONEX · AZSTARYS · Aimovig · Apokyn · Austedo XR · Auvelity · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRILINTA · BRINTELLIX · BrainsWay Deep TMS · Briviact · CAMBIA · CAPLYTA · COMIRNATY · CONTRAVE · Cambia · DAXXIFY · DIVIGEL · DUOPA · Dhivy · ELYXYB - celecoxib · EMGALITY · FANAPT · Fycompa · GOCOVRI · Gamunex-C · Gocovri · HETLIOZ · Hillrom - Carnation Ambulatory Monitor · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LYBALVI · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYDAYIS · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NEURACEQ · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PAXLOVID · PERCEPT PC BRAINSENSE · PLEGRIDY · PURIFIED CORTROPHIN GEL · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · REXULTI · REYVOW · RYTARY · Rebif · SKYCLARYS · SOLIRIS · SPINRAZA · TECFIDERA · TRINTELLIX · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · Xadago · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for optician in NY.
Geographic Context
Opticians within 10 mi
16,392
Per 100K population
1155.0
County median income
$49,036
Nearest hospital
MONTEFIORE MOUNT VERNON HOSPITAL
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Berliner is a mixed practice specialist, with above-average Medicare volume (top 3% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Berliner experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Berliner performed 21,001 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Berliner receive payments from pharmaceutical companies?
Yes. Dr. Berliner received a total of $181,890 from 81 companies across 1,366 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Berliner's costs compare to other opticians in Bronx?
Dr. Berliner's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Berliner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Bronx
Browse opticians in Bronx ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology